Old Web
English
Sign In
Acemap
>
Paper
>
A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS
A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS
2019
William J. Sandborn
J. Panes
Remo Panaccione
G. D'Haens
Bruce E. Sands
Chinyu Su
Michele Moscariello
Thomas V. Jones
R. Pedersen
Gary S. Friedman
Nervin Lawendy
Gary Chan
Keywords:
Clinical trial
Ulcerative colitis
Tofacitinib
Medicine
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]